Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutations in the NS5A gene are associated with response to interferon+ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection.

European journal of gastroenterology & hepatology - 1 Oct 2013

Ullah Sajjad, Rehman Habib U, Idrees Muhammad

Abstract excerpt

INTRODUCTION: The clinical correlation between hepatitis C virus (HCV) NS5A gene mutations and response to antiviral treatment in HCV-3a-infected patients is not as well known as that in HCV-1a-infected and HCV-1b-infected patients. OBJECTIVES: This study attempted to determine mutations in the NS5A gene in isolates of HCV-3a obtained from infected Pakistani patients treated with interferon-α standard therapy and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Ribavirin

Share to Viral Load

Share to Viral Nonstructural Proteins

Source

Identifiers

PMID: 23611896
DOI: 10.1097/MEG.0b013e328360aeb4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutations in the NS5A gene are associated with response to interferon+ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection.PMID 23611896Read ↗

Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein.Semantic proximity Read ↗

Identification Of Mutation Sites In Hepatitis C Virus Genotype 3a In Non-Responders To Combination Therapy With Interferon- Αlfa And Ribavirin In Residents Of Khyber Pakhtunkhwa Province Pakistan.Semantic proximity Read ↗

The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India.Semantic proximity Read ↗

Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population.Semantic proximity Read ↗

A case of a patient infected with a hepatitis C virus genotype 3a multidrug resistant variant in Pakistan.Semantic proximity Read ↗

Predictors of response to antiviral therapy in patients with chronic hepatitis C from Pakistani population.Semantic proximity Read ↗

Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa.Semantic proximity Read ↗

Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis CSemantic proximity Read ↗

Association between IFN-λ 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian Patients.Semantic proximity Read ↗

Amino Acid Mutations in NS5B Protein among Treatment-naive Genotype 3A Infected Patients.Semantic proximity Read ↗

Virological Response to Conventional Interferon Therapy Combined with Ribavirin against Various HCV Genotypes in Khyber Pakhtunkhwa, Pakistan.Semantic proximity Read ↗

Identification of NS5B resistance against SOFOSBUVIR in hepatitis C virus genotype 3a, naive and treated patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.